Nouvelle déclaration d'incident
No de la demande: 2022-6369
Numéro de référence du titulaire d'homologation: 2022-CA-000351
Nom du titulaire (nom légal complet, aucune abbréviation): Wellmark International
Adresse: 100 Stone Road West, Suite 111
Ville: Guelph
État: Ontario
Pays: Canada
Code postal /Zip: N1G 5L3
Incident chez un animal domestique
Pays: CANADA
État: NOVA SCOTIA
Inconnu
ARLA No d'homologation 19209 ARLA No de la demande d'homologation EPA No d'homologation.
Nom du produit: Zodiac Flea and Tick Shampoo for Dogs and Cats
Inconnu
Inconnu
Propriétaire de l'animal
Cat / Chat
Unknown
1
Inconnu
Inconnu
Inconnu
Inconnu
Unknown / Inconnu
Unknown / Inconnu
Système
Persisted until death
Inconnu
Inconnu
Mort
Other / Autre
préciser Unknown
(p.ex. description des symptômes tels que la fréquence et la gravité
On 20 Aug 2022, the animal owner reported the death of their cat. Information regarding possible exposure including amount, route, and possible temporal relationship of exposure to the product is unknown. Follow up was attempted, but the animal owner was unable to be reached. No further information is expected.
Mort
Assessment: This product has a wide margin of safety. Mild dermal irritation is possible following topical use. If inhaled, mild self-limiting respiratory irritation may occur. If ingested, mild self-limiting GI irritation may occur. Death is not expected with labeled use. Further information including route and amount of exposure, temporal relationship, veterinary examination, diagnostics, and necropsy may have been able to provide further insight about the cause of this cats death. Extremely limited information was provided and other causes including other product exposure, trauma, and underlying disease remain in consideration. The information contained in this report is based on self-reported statements provided to the registrant during email correspondence. These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and cannot form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the email correspondence.